Patents by Inventor Yuanjun Gu

Yuanjun Gu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080138453
    Abstract: This invention discloses the uses of chickpea (Cicer arietinum) extract in the preparation of food for the prevention and treatment of obesity and non-insulin-dependent diabetes (NIDD). The invention provides a therapeutic agent and food containing chickpea extract for the prevention and treatment of obesity and NIDD. In this invention, the effect of chickpea extract to the high fat diet fed mice tested by the experiment proves that the chickpea extract can significantly decrease the levels of triglyceride, cholesterol and low density lipoproteins caused by high fat diet taken in a long period of time. Additionally, it is found in the experiments that the chickpea extract can improve the hyposensitivity to insulin. The preparation of the extract is also disclosed herein.
    Type: Application
    Filed: March 6, 2006
    Publication date: June 12, 2008
    Applicant: JUMPSUN BIO-MEDICINE (SHANGHAI) CO., LTD.
    Inventors: Yuanjun Gu, Xiaohua Yue, Ying Yang
  • Publication number: 20060246043
    Abstract: The present invention provides a cellular preparation wherein cells capable of secreting biologically active factors such as hormones or proteins useful for patients can be retained in polyvinyl alcohol stably for a prolonged period of time and a production method of the cellular preparation, and a method for prevention and treatment of endocrine/metabolic disease, hemophilia, bone disease or cancer by administration of the cellular preparation to patients.
    Type: Application
    Filed: November 10, 2003
    Publication date: November 2, 2006
    Inventors: Kazutomo Inoue, Yuanjun Gu, Shoichiro Sumi
  • Publication number: 20060210550
    Abstract: It is intended to provide an angiogenesis inducer comprising fibrin which is safe to a living body. The angiogenesis inducer is characterized by being capable of safely inducing angiogenesis when administered to a living body, which makes it possible to achieve functional regeneration of living tissues or organs suffering from dysfunction or malfunction.
    Type: Application
    Filed: March 28, 2003
    Publication date: September 21, 2006
    Inventors: Kazutomo Inoue, Yuanjun Gu, Dohoon Kim